Drug profile · INN
epoetin alfa-epbx
RETACRIT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
epoetin alfa-epbx (RETACRIT) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN epoetin alfa-epbx
Brand RETACRIT
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is epoetin alfa-epbx?
epoetin alfa-epbx (RETACRIT) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for epoetin alfa-epbx?
RETACRIT is a marketed brand name for epoetin alfa-epbx. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of epoetin alfa-epbx?
epoetin alfa-epbx has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.